The Carlyle Group
Deal focus: China baby boom market comes of age
Warburg Pincus has acquired Chinese mother-and-baby company Leyou, providing an exit for CDIB Capital and The Carlyle Group. The deal signals a rapid maturation process in the segment
Warburg Pincus seals secondary buyout of China's Leyou
Warburg Pincus has agreed to acquire a majority stake in Chinese maternity products supplier Leyou. The deal will facilitate exits for The Carlyle Group and CDIB Capital.
PE and tech investment: The late show
Private equity firms are participating in late-stage rounds in Asia’s technology space as they look to gain a toehold in start-ups with the potential to transform economies. But do the valuations make sense?
PE and tech investment: Forward planning
The growing influence of technology across every industry is forcing PE firms to review approaches to investment. Ensuring the right people have the right information sits at the heart of these efforts
2Q analysis: Flipping out
Flipkart sets the tone as strategics deliver tech trade sale exits; Chinese internet players and healthcare are the trendsetters in investment; buyouts, venture stand out in Asia fundraising
Fund focus: Carlyle tackles growth transformation
The Carlyle Group expects to find more than enough opportunities in Asia's ongoing economic growth for the $6.55 billion corpus of its latest Asia buyout fund
Carlyle closes Asia fund at $6.55b
The Carlyle Group has closed its fifth Asia buyout fund at $6.55 billion, exceeding its predecessor by more than 65%.
Japan outbound M&A: Looking for growth
Unable to find growth at home, Japanese companies are looking for it overseas. Private equity investors can be helpful in everything from execution to integration, provided they can prove their credentials
Carlyle loses India managing director
Devinjit Singh, a managing director for The Carlyle Group based in Mumbai, will leave the firm at the end of this month to pursue other interests.
China's Ant Financial closes $14b Series C round
Ant Financial, Alibaba Group’s financial services affiliate, has raised $14 billion in Series C funding from investors including GIC Private, Warburg Pincus, The Carlyle Group, Silver Lake, and Canada Pension Plan Investment Board (CPPIB).
Australia's Prospa delays trading after $112m IPO
Prospa, an Australian financial technology company backed by a number of local VCs, has raised A$146.5 million ($112 million) in a domestic IPO. Trading of the stock has been postponed, however, amid a regulatory review.
Wine in China: Nurturing the vine
Private equity interest in wine is set to increase as its role in the China luxury goods thesis comes further into focus. Culture, character, and copycatting will be at the top of investors’ strategic agenda
Carlyle hires two Southeast Asia dealmakers
The Carlyle Group has hired Robby Winarta as a managing director for Indonesia and Long Hoang as a director for Vietnam.
Carlyle set for $1.2b cash exit from Korea's ADT Caps
The Carlyle Group has agreed to sell ADT Caps, a South Korean security monitoring and dispatch business, to SK Telecom and Macquarie Group for an enterprise valuation of KRW2.97 trillion ($2.7 billion).
Carlyle hires ex-Kingsoft CEO as senior advisor
The Carlyle Group has appointed former Kingsoft CEO Hongjiang Zhang as a senior advisor to its Asian private equity business. The move is intended to deepen the firm’s coverage of the internet and technology space.
Deal focus: CHAMP wine exit seen as the toast of Australia
CHAMP Private Equity took two divisions of Constellation Brands and turned them into a diversified portfolio of premium wine brands. It has secured a more than 5x money multiple for its efforts
CHAMP sells Australia's Accolade Wines to Carlyle
CHAMP Private Equity has agreed to sell Accolade Wines, which over the course of seven years it has turned into Australia’s largest wine producer, to The Carlyle Group for A$1 billion ($770 million).
CICC commits $286m to China’s Concord Medical
CICC Capital, the private equity arm of China International Capital Corp, has agreed to invest up to RMB1.8 billion ($286 million) in an onshore subsidiary of Concord Medical, a US-listed healthcare business that abandoned a management-led privatization...
VIDEO: The Carlyle Group's Daniel D'Aniello
Daniel D'Aniello, co-founder and chairman emeritus of The Carlyle Group, discusses the evolution of private equity
Carlyle exits Asia containership joint venture
The Carlyle Group has fully exited Greater China Intermodal Investments (GCI), its Asia-focused containership-building joint venture with US-based Seaspan Corporation.
Long-term capital: The patient play
Permanent and long-term capital structures are an attractive proposition for a wide range of players in Asia’s PE market, but bringing them from theory into practice presents numerous challenges
Q&A: Ocean Link's Tony Jiang
Tony Jiang spent a decade at The Carlyle Group before co-founding Ocean Link, China’s first travel and tourism-focused PE firm. He shares his thoughts on the rise sector specialization
China buyouts: Responsible owners
From privatizations to succession planning to corporate carve-outs, China-focused GPs are seeing an increasing number of control buyout opportunities. But are they positioned to take full advantage?
Carlyle hires Goldman executive for China growth deals
The Carlyle Group has hired Wanlian Liu from Goldman Sachs to lead the firm’s growth investments in China as a managing director.